Long-Term Maintenance Plan Weight regain after stopping GLP-1 medications is a well-documented challenge
Stepped up only if medically indicated
Then, thorough consultations determine which surgery is the right one for each individual
These drugs include GLP-1R agonists like Semaglutide, Liraglutide, Dulaglutide, and PEG-Loxenatide, and the GIPR/GLP-1R dual agonist Tirzepatide
Serious but rare risks include pancreatitis, gallbladder disease, and medullary thyroid carcinoma (MTC) patients with personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN2) should not use GLP-1 medications due to black-box contraindications
Starting small is not starting wrong Nobody expects people on semaglutide to walk into a gym and train like athletes